Katsuichi Sudo
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Fibroblast Growth Factor Research 2
- Oncology 6
- Peptidase Inhibition and Analysis 4
- Co-authors
- Takeshi Fujita (4 shared papers)Donald E. Ingber (2 shared papers)TSUNEO KANAMARU (3 shared papers)SHOJI KISHIMOTO (2 shared papers)Judah Folkman (1 shared paper)Harold Brem (1 shared paper)Benita S. Katzenellenbogen (2 shared papers)Frederick J. Monsma (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)The Journal of Antibiotics (2 papers)Nature (1 paper)Molecular and Cellular Endocrinology (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)
- Partner nations
- JapanUnited StatesTunisia
In The Last Decade
Katsuichi Sudo
20 papers receiving 1.9k citations
Katsuichi Sudo's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 479
- Immunology and Allergy 155
- Oncology 551
- Molecular Biology 1.2k
- Biotechnology 98
Countries citing papers authored by Katsuichi Sudo
This map shows the geographic impact of Katsuichi Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuichi Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuichi Sudo more than expected).
Fields of papers citing papers by Katsuichi Sudo
This network shows the impact of papers produced by Katsuichi Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuichi Sudo. The network helps show where Katsuichi Sudo may publish in the future.
Co-authors
The 25 scholars most cited alongside Katsuichi Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Hit paper breakdown → | 1990 | 1158 |
| 2 | 1991 | 292 | |
| 3 | 1983 | 173 | |
| 4 | 1988 | 145 | |
| 5 | 1990 | 71 | |
| 6 | 1983 | 50 | |
| 7 | 1994 | 33 | |
| 8 | 1990 | 26 | |
| 9 | 1993 | 16 | |
| 10 | 1995 | 13 | |
| 11 | 1984 | 11 | |
| 12 | 1991 | 10 | |
| 13 | 1990 | 9 | |
| 14 | 1991 | 9 | |
| 15 | 1991 | 8 | |
| 16 | 1990 | 6 | |
| 17 | 1985 | 5 | |
| 18 | Inhibition of rat urinary bladder carcinogenesis by the antiangiogenic drug TNP-470. | 2006 | 5 |
| 19 | 1984 | 2 | |
| 20 | 1993 | 1 |
About Katsuichi Sudo
Katsuichi Sudo is a scholar working on Molecular Biology, Oncology, Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Genetics, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (4 papers), Estrogen and related hormone effects (3 papers), Endometriosis Research and Treatment (2 papers), Thyroid Disorders and Treatments (2 papers), Fibroblast Growth Factor Research (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Cancer Research (479 citations), Immunology and Allergy (155 citations), Oncology (551 citations), Molecular Biology (1.2k citations) and Biotechnology (98 citations). Katsuichi Sudo has collaborated with scholars based in Japan, United States and Tunisia. Frequent co-authors include Takeshi Fujita, Donald E. Ingber, TSUNEO KANAMARU, SHOJI KISHIMOTO, Judah Folkman, Harold Brem, Benita S. Katzenellenbogen, Frederick J. Monsma, Fumio Itoh and Shogo Marui. Their work appears in journals such as Biochemical and Biophysical Research Communications, The Journal of Antibiotics, Nature, Molecular and Cellular Endocrinology and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.